Poster Sessions

Thursday, May 19

7:00-7:50 am - Poster set-up

12:05-1:20 pm - Poster session

Friday, May 20

12:50-1:50 pm - Poster session

3:35-4:00 pm - Coffee break – Removal of all Posters

Poster Specifications and Preparation Information

• All text on the poster should be in font size no smaller than 16 pt. and must be visible from a distance of about 2-3 feet.
• Illustrations and photos should contain captions.
• At least one abstract author must be present to participate in the interactive poster sessions.
• Authors are strongly encouraged to bring letter size reprints of their posters to the meeting for distribution

      (There will not be a copy machine at the meeting venue; bring additional copies for distrubtion)

• Poster size must be no larger than 44" wide x 44" high.
• Push pins will be provided.
• Poster numbers will be provided on the day of the meeting. 

Posters

1. 2016 Journal of Lipid Research Junior Investigator Award - Lipoxin A4 and lipoxin B4 attenuate adipose tissue inflammation in obese patients – Emma Börgeson, Ville Wallenius, Per Björklund, Marianne Quiding-Järbrink, Kumar Sharma, Catherine Godson (Institute of Clinical Sciences, Department of Gastrosurgical Research and Education and Diabetes Complications Research Centre, School of Medicine and Medical Sciences, Conway Institute, University College Dublin, England)
2. APOE4 genotype dependent deficits in DHA containing phospholipids and DHA transporters in the cerebrovasculature of Alzheimer’s disease patients - Laila Abdullah , James E. Evans, Ben Shackleton, Joseph O. Ojo, Thinh Nguyen, Jon Reed, Michael Mullan, Fiona Crawford and Corbin Bachmeier (Roskamp Institute, Sarasota, FL, USA)
3. Adipose prostaglandin D2 enhances body weight gain and suppresses lipolysis through DP2 receptors - Ko Fujimori, Eri Wakai, Kosuke Aritake, Yo Oishi, Nanae Nagata, Fumio Amano, Michael Lazarus, and Yoshihiro Urade (Osaka University of Pharmaceutical Sciences and Osaka Bioscience Institute, Osaka, Japan)
4. MGST2-generated LTC4 is the major mediator of stress-triggered DNA damage - Efrat Dvash, Adi Katov and Menachem Rubinstein (Department of Molecular Genetics, The Weizmann Institute of Science, Rehovot, Israel)
5. APOE ε4 increases the ratio of serum phospholipid arachidonic acid to docosahexaenoic acid and aids in the identification of individuals with preclinical Alzheimer’s disease - James E. Evans, Laila Abdullah, Tanja Emmerich, Thinh Nguyen, Gogce Crynen, Ben Shackleton, Jon Reed, Andrew P. Keegan, Cheryl Luis, Leon Tai, Mary J. LaDu, Michael Mullan, Fiona Crawford and Corbin Bachmeier (Roskamp Institute, Sarasota, FL, USA)
6. Pigment epithelium-derived factor (PEDF) regulation of docosanoid-mediated signaling enhances corneal nerve regeneration by targeting neurotrophins, semaphorins, and regeneration associated genes (RAGs) - Thang Luong Pham, Azucena Kakazu, Jiucheng He, Haydee H.P. Bazan (Louisiana State University Health New Orleans, School of Medicine,  Neuroscience Center of Excellence, New Orleans, LA, USA)
7. Subcellular localization of a 2-arachidonoyl glycerol signaling cassette in developing retinal ganglion cell axons is consistent with formation of hotspots - David T. Stark, Joseph Caprioli (Stein Eye Institute, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA)
8. Normalizing membrane phospholipid derangement from epigenetic insults in neurological disease with lipids and resolvins – Patricia C. Kane, Shideh Pouria, Annette L. Cartaxo, Kristine Gedroic, Damien Downing, Thomas Wnorowski, Edward Kane, Mark O’Neal Speight (Director, NeuroLipid Research Foundation, Millville, New Jersey, USA)
9. Maresin 1 modulates hypoxia-induced and lipotoxic ER stress in primary hepatocytes – Bibiana Rius, Esther Titos, Cristina López-Vicario, A. Lopategi, Mireia Casulleras, José Alcaraz-Quiles, Joan Clària (Department of Biochemistry and Molecular Genetics, Hospital Clínic-IDIBAPS, Barcelona, Spain)
10. Identification of cyclooxygenase-related enzymes in bacteria - Zahra Mashhadi, William E. Boeglin, and Alan R. Brash (Department of Pharmacology and The Vanderbilt Institute of Chemical Biology, Vanderbilt University, Nashville, TN, USA)
11. Prostaglandin D₂ DP1 receptor ameliorates, stroke outcomes through cerebral blood flow and homeostasis – Abdullah Shafique Ahmad, Thomas M. Dougherty, Shah Narumiya, and Sylvian Dore (Department of Anesthesiology, Center for Translational Research and Neurodegenerative Disease, University of Florida, Gainesville, FL, USA)
12. Alterations in lysophoshatidylcholine-related metabolic parameters in the plasma of mice with bacterial peritonitis – Won-Gyun Ahn, Jun-Sub Jung, Hyeok-Yil Kwon, and Dong-Keun Song (Departments of Pharmacology, College of Medicine, Hallym University, Chunchon, S. Korea)
13. The role of diplamitoylphosphatylcholine produced by lysophosphatidycholine acyltransferase 1 in polyunsaturated fatty acid-induced cytotoxity – Sosuke Akagi, Nozomu Kono, Hiroyuki Ariyama, Hideo Shindou, Takao Shimizu, and Hiroyuki Arai (Department of Health Chemistry, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan)
14. Lipocalin-type prostaglandin D synthase: a transporter of prostaglandin D₂ and scavenger of prostaglandin D₂-degraded products – Kosuke Aritake, Shigeru Shimamoto, and Yoshihiro Urade (Molecular Sleep Biology, International Institute for Integrative Sleep Medicine (IIIS), University of Tsukuba, Ibaraki, Japan and Osaka Bioscience Institute, Osaka, Japan)
15. Neuroprotectin D1 (NPD1) stereoselectively modulates inflammasome transcription and activation in human retinal pigment epithelial cells – Aram Asatryan and Nicolas G. Bazan (Neuroscience Center of Excellence, School of Medicine, LSU Health New Orleans, New Orleans, LA, USA)
16. PUFA-mediated proinflammatory to ionizing radiation – Evagelia C. Laiakis, Katrin Strassburg, Steven Lai, Rob J. Vreeken, Thomas Hankemeier, Rob Plumb, Albert J. Fornance Jr., and Giuseppe Astarita (Department of Biochemistry and Molecular & Cellular Biology, Georgetown University, Washington DC and Waters Corporation, Health Sciences, Milford, Massachusetts, USA)
17. PLA2G5-expressing M2 macrophages in mouse and human type 2 inflammation – Munehiro Yamaguchi, Jennifer Zacharia, Tanya M. Laidlaw, and Barbara Balestrieri (Department of Medicine, Harvard Medical School; Jeff and Penny Vinik Center for Allergic Disease Research, Division of Rheumatology, Immunology and Allergy, Brigham and Women’s Hospital, Boston, MA, USA)
18. Very long-chain fatty acid-containing phosphotidylcholine molecular species are altered in age-related macular degeneration (AMD) – Surjyadipta Bhattacharjee, Bokkyoo Jun, William C. Gordon, Nicolas G. Bazan (Neuroscience Center of Excellence, School of Medicine, Louisiana State University Health New Orleans, New Orleans, LA, USA)
19. Sphingosine 1-phosphate bound to ApoM+HDL modulates generation of the adaptive immune response at different stages of lymphocyte ontogeny – Victoria A. Blaho, Sylvian Galvani, Eric Engelbrecht, Catherine Liu, Steven L. Swendeman, Mari Kono, Richard L. Proia, Lawrence Steinma, May H. Han, and Timothy Hla (Center for Vascular Biology, Department of Pathology and Laboratory Medicine, and Brain and Mind Research Institute, Weill Medical College of Cornell University, New York, NY, USA)
20. Rapid normal-phase separation of lysophosphatidic acid and other lysophospholipids by ultra-high performance supercritical fluid chromatography ­– Joost Brandsma, Thomas Sutton, Julie Herniman, Clair Brooke, Anthony Postle, Timothy Jenkins, and John Langely (University of Southampton, Faculty of Medicine, Southampton, UK)
21. Novel regulatory mechanism of the inflammatory response mediated by Neuroprotectin D1 (NPD1) targeting transcription of Wnt5a – Jorgelina Calandria and Nicolas G. Bazan (Neuroscience Center of Excellence, School of Medicine, Louisiana State University Health New Orleans, New Orleans, LA, USA)
22. Novel omega-3 endocannabinoid epoxides emnating from the cross-talk between the endocannabinoid and cytochrome P450 metabolic pathways – Daniel R. McDougle and Aditi Das (Department of Comparative Biosciences, Department of Biochemistry, Department of Nutrional Sciences, University of Illinois Urbana-Champaign, Urbana, IL, USA)
23. A defect in ∆⁶ and ∆⁵ desaturases may be a factor predisposing to insulin resistance, obesity and metabolic syndrome – Undurti N. Das (UND Life Sciences, Federal Way, WA, USA)
24. Soluble-amyloid precursor protein α (sAPPα) and neuroprotectin D1 (NPD1) engage in a beneficial cycle to sustain human retinal pigment epithelial cell integrity when confronted with the onset of dysfunction – Khanh Do and Nicolas G. Bazan (Neuroscience Center of Excellence, School of Medicine, Louisiana State University Health New Orleans, New Orleans, LA, USA)
25. Cysteinyl leukotriene 2 receptor enhances angiogenesis, vasular permeability and tumor metastasis – Ernest Duah, Vinay Kondeti, Nosayba Al-Azzam, Ravi Adapala, Prachi Patil, Charles Thodeti, and Sailaja Paruchuri (Department of Chemistry, University of Akron, Akron, OH, USA)
26. Lung edema and mortality induced by scorpion venom are mediated by inflammasome activation and regulated by eicosanoids – Karina F. Zoccal, Carlos A. Sorgi, Juliana I. Hori, Francisco W.G., Paula-Silva, Eliane C. Arantes, Carlos H. Serezani, Dario S. Zamboni, and Lúcia Helena Faccioli (Departamento de Análises Clínicas, Toxicológicas e Bromatológicas, Universidade de São Paulo, Ribeirão Preto, São Paulo, Brazil)
27. Pseudomonas aeruginosa promotes persistent inflammation in the cystic fibrosis airway by preventing the generation of 15-epi liposin A₄ – Becca A. Flitter, Kelli L. Hvorecny, Emiko Ono, Taylor Eddens, Jun Yang, Daniel H. Kwak, Christopher D. Bahl, Christophe Morisseau, Bruce D. Hammock, Xinyu Liu, Janet S. Lee, Jay K. Kolls, Bruce D. Levy, Dean R. Madden, and Jennifer M. Bomberger (Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA)
28. A heart-liver metabolic circuit mediated by a cardiac-specific secreted PLA₂ –S. Hernandez-Anzaldo, E. Berry. V. Brglez, D. Leung, TJ Yun, JG Filep, Z. Kassiri, C. Cheong, M. Murakami, MH Gelb, G. Lambeau, R. Lehner, and Carlos Fernandez-Patron (Department of Biochemistry, Cardiovascular Research Group and Mazankowski Alberta Heart Institute, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada)
29. A therapeutic approach for experimental ischemic stroke combining a PAF-receptor antagonist plus docosanoids – Raul Sousa Freitas, Shawn J., Marcell, Hemant Menghani, Sung-Ha Hong, Larissa Khoutorova, Andre Obenaus, Nicos A. Petasis, Ludmila Belayev, and Nicolas G. Bazan (Neuroscience Center of Excellence, School of Medicine, Louisiana State University Health New Orleans, New Orleans, LA, USA)
30. Cardioprotection following injury heart failure afforded by a non-enzymatic oxygenated metabolite of omega 3 fatty acid involves Ryanodine receptor mechanism and mitochondrial function – J. Roy, C. Oger, J. Fauconnier, J. C. Y. Lee, C. Farah, P. Bideaux, V. Scheurmann, V. Bultel-Ponce, C. Vigor, A. Lacampagne, Jean-Marie Galano, T. Durand, and J-Y. Le Guennec (Institut des Biomolécules Max Mousseron, CNRS UMR 5247, Université de Montpellier, ENSCM, Montpellier, France)
31. GIIA-Phospholipases A ₂ Isolated from snake venoms induce vascular smooth muscle foam cell formation – Karina C. Giannotti, Elbio Leiguez, Mariana N. Viana, Neide Galvão do Nascimento, Thais L. Araújo, Renata H. A. Hernandez, Suely Sampaio, Bruno Lomonte, and Catarina Teixeira (Laboratório de Farmacologia, Instituto Butantan, São Paulo/SP, Brazil)
32. The 5-LOX/COX-2 cross-over eicosanoid HKE₂ modulates platelet aggregation – Juan Antonio Gimenez Bastida and Claus Schneider (Division of Clinical Pharmacology, Department of Pharmacology, Vanderbilt University, Nashville, TN, USA)
33. Very long-chain polyunsaturated fatty acid/DHA-containing phosphatidylcholine molecular species show gender-specific changes in age-related macular degeneration (AMD) – William C Gordon, Bokkyoo Jun, Uday Patel, Nicolas G. Bazan (Neuroscience Center of Excellence, School of Medicine, Louisiana State University Health New Orleans, New Orleans, LA, USA)
34. Prostaglandin F_2α FP receptor antagonist improves outcomes after experimental traumatic brain injury – Alexander V. Glushakov, Sean W. Robbins, Connor L. Bracy, Shuh Narumiya, and Sylvian Doré (Department of Anesthesiology, University of Florida College of Medicine, Gainesville FL, USA)
35. Role of group VIB calcium-independent phospholipase A₂ (iPLA_2γ) in carcinogenesis – Shuntaro Hara, Yuka Sasaki, Yuhki Morikaku, Ryosuke Yamada, Reiko Hirai, and Emiko Yoda (Division of Health Chemistry, Department of Healthcare and Regulatory Sciences, Showa University, School of Pharmacy, Tokyo, Japan)
36. Molecular organization of specific phosphotidycholine (PC) lipid mediators containing novel very long chain polyunsaturated fatty acids (VLC-PUFAs) in the human retina – Jarrod C. Harman, Bokkyoo Jun, Uday Patel, William C. Gordon, and Nicolas G. Bazan (Neuroscience Center of Excellence, School of Medicine, Louisiana State University Health New Orleans, New Orleans, LA, USA)
37. Docosahexaenoic acid-derived lipids in human rod and cone photoreceptor cells – H. Elizabeth Hill, William C. Gordon, Bokkyoo Jun, and Nicolas G. Bazan (Neuroscience Center of Excellence, School of Medicine, Louisiana State University Health New Orleans, New Orleans, LA, USA)
38. PNPLA 7-mediated catabolic pathway for phosphatidycholine has a crucial role in hepatic choline metabolism and systemic energy homeostasis – Tetsuya Hirabayashi, Misa Mouri, Suzumi M. Tokuoka, Yoshihiro Kita, Rieko Nakata, Kazutaka Ikeda, and Makoto Murakami (Lipid Metabolism Project, Tokyo Metropolitan Institute of Medical Science and AMED-CREST, AMED Tokyo, Japan)
39. Quantification of sphingosine 1-phosphate in plasma of colorectal carcinoma patients by LC-MS/MS – Wei Hu, Bo Yang, Gaofeng Hu, Lei Yin, Xu Zhao, Zhengwu Guo, Linzhange Li, Pengfei Song, Jingkai Gu, and Wei Xu (Department of Clinical Laboratory, The First Hospital of Jilin University, Changchun, PR China)
40. UPLC-MS/MS identifies lipids associated with perceptual speed performance in healthy adults. Kevin Huynh, Virginie Lam, Matthew Albrecht, Corey Giles, Ryusuke Takechi, John Mamo, Peter J Meikle, (Baker IDI Heart and Diabetes Institute and Monash University, Melbourne, Australia).
41. Biallelic deletions in MBOAT7 link phosphatidylinositol lipid remodeling to autism spectrum disorders – Anide Johansen, Rasim Rosti, Damir Musaev, Evan Sticca, Berit Johansen, Maha Zaki, Matloob Azam, Tipu Sultan, Rami A. Jamra, and Joseph G. Gleeson (Laboratory of Pediatrics Brain Disease, Department of Neurosciences, University of California, San Diego, CA, USA)
42. Novel Inhibitor of cytosolic group IVA phospholipase A2 (cPLA2α) has shown “Proof of concept” in treatment of psoriasis – Berit Johansen, Astrid J. Freuerherm, Silje H. Omland,and Robert Gniadecki (Department of Biology, Norwegian University of Science and Technology, Trondheim, Norway)
43. c-Fos reporter reveals astrocytic activity modulated by S1P – signaling in experimental autoimmune encephalomyelitis – Deepa Jonnalagadda, Aran Groves, Yasuyuki Kihara, and Jerold Chun (Department of Molecular and Cellular Neuroscience, The Scripps Research Institute, La Jolla, CA, USA)
44. Oleoylethanolamide improves phospholipid profiles and reduces astroglia activation in a mouse model of Gulf War Illness – Utsav Joshi, James E. Evans, Thinh Nguyen, Austin Seroka, Gary Laco, Michael Mullan, Fiona Crawford, and Laila Abdullah (Roskamp Institute, Sarasota, FL, USA)
45. Docosahexaenoyl acyl chains of membrane phospholipids and retina function – Bokkyoo Jun, Robert F. Rosencrans, Hamilton E. Farris, Corinne Richards-Zawacki, William C. Gordon, and Nicolas G. Bazan (Neuroscience Center of Excellence, School of Medicine, Louisiana State University Health New Orleans, New Orleans, LA, USA)
46. Membrane-type Frizzled Related Protein (MFRP) participates in docosahexaenoic acid (DHA) retention in the retina and contributes to photoreceptor cell function – Marie-Audrey I. Kautzmann, Bokkyoo Jun, William Gordon, and Nicolas Bazan (Neuroscience Center of Excellence, School of Medicine, Louisiana State University Health New Orleans, New Orleans, LA, USA)  
47. Evaluating PLA activity by LPLAT inhibition using ACAT inhibitor – Hiroki Kawana and Junken Aoki (Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan)
48. S1P signaling in an animal model of Multiple Sclerosis – Yasuyiki Kihara, Richard Rivera, Shaun R. Coughlin, and Jerold Chun (Department of Molecular and Cellular Neuroscience, Dorris Neuroscience Center, The Scripps Research Institute, LaJolla, CA, USA)
49. Beta-lactones as a novel class of calcium-independent phospholipase A₂ inhibitors – C. Dedaki, V. Magrioti, M. G. Kokotou, D. Limnios, V. Mouchlis, B. Sapathy, E. A. Dennis, and G. Kokotos (Department of Chemistry, National and Kapodistrian University of Athens, Panepistimiopolis, Athens, Greece)
50. 2-Oxoesters: Development of a novel class of potent and selective inhibitors of cytosolic group IVA phospholipase A₂ – M. G. Kokotou, G. Galiatsatou, V. Magrioti, G. Koutoulogenis, E. Barbayianni, D. Limnios, V. Mouchlis, B. Satpathy, E. A. Dennis, and G. Kokotos (Department of Chemistry, National and Kapodistrian University of Athens, Panepistimipolis, Athens, Greece)
51. Leukotriene D₄ and prostaglandin E₂ synergism in inflammation and asthma – Vinay Kondeti, Nosayba AlAzzam, Ernest Duah, Charles K. Thodeti, and Sailaja Paruchuri (Department of Chemistry, University of Akron, Akron, OH, USA)
52. Distinguishing lipid mediators with ion mobility spectrometry and mass spectrometry – Jennifer E. Kyle, Daniel J. Orton, Kristin E. Burnum-Johnson, Xueyun Zheng, Matthew E. Monroe, Richard D. Smith and Erin S. Baker (Biological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, USA)
53. Metabolic pertubations of postnatal growth restriction and hyperoxia-induced neonatal pulmonary hypertension in a rat model of bronchopulmonary dysplasia – Michael R. La Frano, Johannes F. Fahrmann, Dmitry Grapov, John W. Newman, Oliver Fiehn, Karen Mestan, Robin H. Steinborn, and Stephen Wedgwood (NIH West Coast Metabolomics Center and Department of Nutrition, University of California Davis, Davis, CA, USA)
54. Modulation of blood accumulation and angiogenic responses by PGE₂-EP3 signaling after ICH in aged mice – Jenna L. Leclerc, Andrew S. Lampert, Matthew Diller, and Sylvain Dore (Department of Anesthesiology and Center for Translational Research in Neurodegenerative Disease, University of Florida, Gainesville, FL, USA)
55. PGE₂ EP 1-4 receptor expression levels after intracerebral hemorrhage in young, aged, and EP1 deficient mice – Jenna L. Leclerc, Andrew R. Fadool, Julie C. Bailes, Chase Chambers, and Sylvain Dore (Department of Anesthesiology and Center for Translational Research in Neurodegenerative Disease, University of Florida, Gainesville, FL, USA)
56. Study of the beta-sulfur effect on the activity of the PLA₂ inhibitors based on activated carbonyls – D. Limnios, M.G. Kokotou, E. Barbayianni, A. Psarra, V. Mouchlis, E. A. Dennis, and G. Kokotos (Department of Chemistry, National and Kapodistrian University of Athens, Panepistimiopolis, Athens, Greece and Departments of Chemistry and Biochemistry & Department of Pharmacology, School of Medicine, University of California, San Diego, La Jolla, CA, USA)
57. Docosanoid-mediated neuroprotection in experimental ischemic stroke – Shawn J. Marcell, Raul Sousa Freitas, Hemant Menghani, Ludmila Belayev, Larissa Khoutorova, Andre Obenaus, and Nicolas G. Bazan (Neuroscience Center of Excellence, School of Medicine, Louisiana State University Health New Orleans, New Orleans, LA, USA)
58. Efficacy of laropiprant in ameliorating hyperglycemia-mediated intracerebral hemorrhage – Monique Mendes, Sherry Ali, Sylvain Dore, and Abdullah Shafique Ahmad (Department of Anesthesiology and Center for Translational Research in Neurodegenerative Disease, University of Florida, Gainesville, FL, USA)
59. Novel interactions between phosphorylated-endocannabinoids and LPA receptors – Hirotaka Mizuno, Yasuyuki Kihara, Douglas Sheffler, and Jerold Chun (Department of Molecular and Cellular Neuroscience, Dorris Neuroscience Center, The Scripps Research Institute, La Jolla, CA and Exploratory Research Laboratories, Ono Pharmaceuticals Company, Ltd., Ibaraki, Japan)
60. Allosteric regulation of phospholipase A₂ by membranes – Varnavas D. Mouchlis, J. Andrew McCammon, and Edward A. Dennis (Department of Pharmacology, Department of Chemistry and Biochemistry, University of California San Diego, La Jolla, CA, USA)
61. Neuroprotectin D1 (NPD 1) targets Sirtuin in retinal pigment epithelial cell survival signaling under-uncompensated oxidative-stress – Pranab K. Mukherjee and Nicolas G. Bazan (Neuroscience Center of Excellence, School of Medicine, Louisiana State University Health New Orleans, New Orleans, LA, USA)
62. Macrophage eicosanoid biosynthesis elicited by oxidized phospholipids and oxidized low density lipoprotein – Aaron R. Navratil, Oswald Quehenberger, Philipp Wiesner, Eric Montano, Joseph L. Witztum, and Edward A. Dennis (Department of Chemistry and Biochemistry and Department of Pharmacology, School of Medicine, University of California San Diego, La Jolla, CA, USA)
63. Resolvin D3 multi-level proresolving actions are host protective during infection – Paul C. Norris, Hildur Arnardottir, Julia M. Sanger, David Fichter, Greg Keyes, and Charles N. Serhan (Center of Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative and Pain Medicine, Harvard Institutes of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA)
64. Inhibition of TRPV4 mediated signaling decreases TGF-β1 induced fibroblast differentiation and ameliorates house dust mite induced asthma in mice – Farai C. Gombedza, Vinay K. Kondeti, Nosayba Al-Azzam, Stephanie Koppes, Madison A. Hexter, Ernest Duah, Prachi K. Patil, Charles K. Thodeti, and Sailaja Paruchuri (Department of Chemistry, University of Akron, Akron, OH, USA)
65. Mast cell activation by hyperosmolar mannitol-challenge in isolated human small airways – Jesper Säfholm, Johan Bood, Sven-Erik Dahlén and Mikael Adner (Experimental Asthma and Allergy Research, Karolinska Instiututet, Stockholm, Sweden)
66. Critical role for prostacyclin synthase in a contact hypersensitivity mouse model – Yuka Sasaki, Tsubasa Ochiai, Chieko Yokoyama, and Shuntaro Hara (Division of Health Chemistry, Department of Healthcare and Regulatory Sciences, School of Pharmacy, Showa University, Tokyo, Japan)
67. Sphingosine kinase 2 deficiency increases proliferation and migration of renal mouse mesangial cells – Stephanie Schwalm, Tanicka Maneva Timcheva, Iuliia Filipenko, Mahsa Ebadi, Lotte P. Hofmann, Uwe Zangemeister-Wittke, Josef Pfeilschifter and Andrea Huwiler (Pharmazentrum Frankfurt/ZAFES, Klinikum der Goethe-Universität, Frankfurt am Main, Germany and Institute of Pharmacology, University of Bern, Bern, Switzerland)
68. Regulation of arachidonic acid metabolism by PLA₂ enzymes in cancer – Kieran F. Scott, Mila Sanjinovic, W. Bret Church, Paul de Souza, and Qihan Dong (School of Medicine, Southwest Sydney Clinical School, UNSW, Centre for Oncology Education and Research Translation (CONCERT), Ingham Institute of Applied Medical Research, Liverpool, NSW, Australia)
69. The role of oxidized phaspholipid-derived lipid mediators in IgE-mediates mast cell activation – Yuta Shimanaka, Nozomu Kono, Yoshitaka Taketomi, Makoto Arita, Makoto Murakami, and Hiroyuki Arai (Department of Health Chemistry, Graduate School of Pharmaceutical Sciences the University of Tokyo, Japan)
70. Modulatory effect of melanoma cells on tumor-associated macrophage eicosanoid metabolism – Carlos Arterio Sorgi, Luana Da Costa Loureiro, Luma Da Costa Loureiro, Edson Alves Gabriel Junior, Raphel Luis Sanchez, and Lucia Helena Faccioli (Faculdade de Ciências Farmacêuticas de Ribeirão Preto – FCFRP, Universidade de Sao Paulo (USP), Ribeirão Preto, Brazil; Universidade Federal do Amazonas (UFAM), Instituto de Ciências Biológicas, Manaus, Brazil)
71. Fatty acid mediators are critical for male fertility in Drosophila – Eli Miller, Geulah Ben-David, Yosef Frenkel, Sogol Eizadshenass, and Josefa Steinhauer (Department of Biology, Yeshiva University, New York, NY, USA)
72. Roles of prostaglandin EP4 receptor in adipose tissue – Yukihiko Sugimoto, Tomoaki Inazumi, Soken Tsuchiya, and Shuh Narumiya (Graduate School Pharmaceuticals Science, Kumamoto University, AMED-CREST, Kumamoto, Japan)
73. Defining the binding mode of a potent inhibitor in the active site of lipoprotein associated phospholipase A₂ – Alexis Vasquez, Varnavas D. Mouchlis, Jian Cao, J. Andrew McCammon, and Edward A. Dennis (Department of Pharmacology and Department of Chemistry and Biochemistry, University of California San Diego, La Jolla, CA, USA)
74. The two secreted phospholipase A₂s PLA2G2F and PLA2G2E play distinct roles in skin homeostasis and disease – Kei Yamamoto, Yoshimi Miki, Hiroyasu Sato, Yoshitaka Taketomi, Gérard Lambeau, Michael H. Gelb, and Makoto Murakami (Lipid Metabolism Project, Tokyo Metropolitan Institute of Medical Science; Faculty of Bioscience and Biotechnology, Tokushima University, Tokushima, Japan)
75.  Photoreceptor protective bioactivity of NPD1 and dendrimer nanoparticle-conjugated NPD1 in  the S334-ter-5 model of retinitis pigmentosa – Raymond Iezzi, Yousef J. Cruz-Iñigo, Manoj Mishra, William C. Gordon, Rong Yang, Nicos A. Petasis, Rangaramanujam M. Kannan, Nicolas G. Bazan (Neuroscience Center of Excellence, School of Medicine, Louisiana State University Health New Orleans, New Orleans, LA, USA)